Weight loss and type 2 diabetes resolution is similar to a Roux-en-Y gastric bypass, without the surgery.

Read More about EndoBarrier™ >>

Emerging clinical evidence supports the need for metabolic control in obesity and type 2 diabetes treatment.

Find out More >>

Defining Noninvasive Metabolic Control 

Metabolic diseases such as obesity and type 2 diabetes have reached epidemic proportions worldwide. GI Dynamics is defining important new options for people who need to take control of their weight and their health.  The EndoBarrier™ technology is designed to modify metabolic pathways by lining a portion of the gastrointestinal tract. This is done via an endoscopic procedure. This noninvasive approach may represent a significant advancement over traditional pharmaceutical and surgical interventions.

 

The EndoBarrier™ is an investigational device. It is currently in clinical trials and is not yet commercially available.